Igor Bilinsky Iovance Biotherapeutics, Inc. (IOVA) insider trading activity

Igor Bilinsky is Chief Operating Officer of IOVANCE BIOTHERAPEUTICS, INC.. Currently has a direct ownership of 87,578 shares of IOVA, which is worth approximately $311,777. The most recent transaction as insider was on Apr 14, 2023, when has been sold 2,812 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 87.6K

52.21% 3M change

139.02% 12M change

Total Value Held $311,777

IGOR BILINSKY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 14 2023	BUY Exercise of conversion of derivative security	-	2,812 Added 9.37%	27,190 Common Stock
Jan 17 2023	SELL Payment of exercise price or tax liability	$30,034 $6.43 p/Share	4,671 Reduced 16.08%	24,378 Common Stock
Jan 17 2023	BUY Exercise of conversion of derivative security	-	11,248 Added 27.91%	29,049 Common Stock
Jan 03 2023	SELL Payment of exercise price or tax liability	$64,478 $6.11 p/Share	10,553 Reduced 37.22%	17,801 Common Stock
Jan 03 2023	BUY Exercise of conversion of derivative security	-	18,850 Added 39.93%	28,354 Common Stock
Jun 14 2022	SELL Payment of exercise price or tax liability	$72,245 $7.73 p/Share	9,346 Reduced 49.58%	9,504 Common Stock
Jun 14 2022	BUY Exercise of conversion of derivative security	-	18,850 Added 50.0%	18,850 Common Stock

Also insider at

ONCT

Oncternal Therapeutics, Inc. Healthcare

Chief Business Officer

Igor Bilinsky

Chief Operating Officer

San Carlos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IOVA shares.

Notify only if

Value

Insider Trading

Get notified when an Iovance Biotherapeutics, Inc. insider buys or sells IOVA shares.

Notify only if

Operation

Value

Type

News

Receive news related to IOVANCE BIOTHERAPEUTICS, INC.

Track Activities on IOVA

Account